Having found its sweet spot bridging the middle markets of Asia and Europe, AGIC Capital plans to stay there – although Fund II will move earlier to capture technology hardware post-commercialization
AGIC Capital has positioned itself carefully on the Asia-Europe axis. There has always been a strong China angle: it is the growth story most European portfolio companies want to access; there is a history,...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.